Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Current Oncology Reports|October 15, 2011
The "SWOT" of BRAF inhibition in melanoma: RAF inhibitors, MEK inhibitors or both?Moriah H Nissan, David B SolitCancer Discovery|July 13, 2013
ERK pathway inhibitors: how low should we go?Moriah H Nissan, Neal Rosen, David B SolitJAMA Oncology|January 9, 2025
Genetic Ancestry-Based Differences in Biomarker-Based Eligibility for Precision Oncology TherapiesKanika Arora, Sarah P Suehnholz, Hongxin Zhang, et al.Cancer Research|March 1, 2014
Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependenceMoriah H Nissan, Christine A Pratilas, Alexis M Jones, et al.Cancer Discovery|October 18, 2023
Quantifying the Expanding Landscape of Clinical Actionability for Patients with CancerSarah P Suehnholz, Moriah H Nissan, Hongxin Zhang, et al.Cancer Research|July 10, 2020
Leveraging Systematic Functional Analysis to Benchmark an In Silico Framework Distinguishes Driver from Passenger MEK Mutants in CancerAphrothiti J Hanrahan, Brooke E Sylvester, Matthew T Chang, et al.JCO Precision Oncology|September 12, 2017
OncoKB: A Precision Oncology Knowledge BaseDebyani Chakravarty, Jianjiong Gao, Sarah M Phillips, et al.Pageof 1